Summary:
The aim was to analyze quality-of-life (QOL) during the first year post transplant in 47 patients undergoing reduced-intensity conditioning (RIC) allotransplantation, and to compare these with a similar subgroup of patients receiving autologous stem cell transplantation (ASCT). We used self-reported questionnaires. Each answer scored from 0 (not at all) to 4 (very much), with higher scores indicating worse functioning. Mean value of physical categories among RIC transplants ranged between 1.23 and 0.77 indicating that patients scored very low for physical symptoms. Patients undergoing ASCT had higher scores in questionnaires performed early after transplant and then gradually improved (P<0.001). Overall, when we compared physical functioning scores, allo-RIC did significantly better (P=0.049). Nevertheless, while allo-RIC scores were significantly better for the first three questionnaires, ASCT patients did better in the last two questionnaires. These findings are in accordance with the toxicities observed in both subgroups which are lower in the RIC group early after transplant. No significant differences were observed between either subgroup for any of the functional, social/ family, psychological distress and satisfaction with doctor/nurse relationship items. We have observed similar QOL among patients undergoing RIC-allo as compared to ASCT although GVHD remains an important ‘event’ in QOL.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Woolf SH . Shared decision making: the case for letting patients decide which choice is best. J Fam Pract 1997; 45: 205–208.
Silver RT, Woolf SH, Hehlmann R et al. An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukaemia: developed for the American Society of Haematology. Blood 1999; 5: 1517–1536.
Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukaemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217–223.
Sebban C, Lepage E, Vernant JP et al. Allogeneic bone marrow transplantation in adult acute lymphoblastic leukaemia in first complete remission: a comparative study. French group of therapy of adult acute lymphoblastic leukaemia. J Clin Oncol 1994; 12: 2580–2587.
Gianni AM, Bregni M, Siena S et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997; 18: 1290–1298.
Philip T, Guglielmi C, Hagenbeek A et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 23: 1540–1545.
Worel N, Biener D, Kalhs P et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation. Bone Marrow Transplant 2002; 30: 619–626.
Chao NJ, Tierney K, Bloom JR et al. Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood 1992; 80: 825–830.
Hjermstad MJ, Evensen SA, Kvaloy SO et al. Health-related quality of life 1 year after allogeneic or autologous stem-cell transplantation: a prospective study. J Clin Oncol 1999; 17: 706–718.
Heinonem H, Volin L, Uutela A et al. Quality of life and factors related to perceived satisfaction with quality of life after allogeneic bone marrow transplantation. Ann Hematol 2001; 80: 137–143.
Kiss TL, Abdolell M, Jamal N et al. Long-term medical outcomes and quality of life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation. J Clin Oncol 2002; 20: 2334–2343.
Neitzert CS, Ritvo P, Dancey J et al. The psychosocial impact of bone marrow transplantation: a review of the literature. Bone Marrow Transplant 1998; 22: 409–422.
Kopp M, Schweigkofler H, Holzner B et al. Time alter bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality of life assessment. Ann Hematol 1998; 77: 27–32.
Syrjala KL, Chapko MK, Vitaliano PP et al. Recovery alter allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993; 11: 319–327.
Zittoun R, Suciu S, Watson M et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission alter bone marrow transplantation (allogeneic or autologous) or chemotherapy: a cross-sectional study of EORTC-GIMEMA AML 84 trial. Bone Marrow Transplant 1997; 20: 307–315.
Andrykowski MA, Henslee-Downey PJ, Farral MG . Physical and psychosocial functioning of adult survivors of allogeneic bone marrow transplantation. Bone Marrow Transplant 1989; 4: 75–81.
Belec RH . Quality of life: perceptions of long-term survivors of bone marrow transplantation. Oncol Nurs Forum 1992; 19: 31–37.
Jenkins PL, Linington A, Whittaker JA . A retrospective study of psychosocial morbidity in bone marrow transplantation recipients. Psychosomatics 1991; 32: 65–71.
Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal citoreduction for the treatment of malignant and non malignant hematologic diseases. Blood 1998; 91: 756–763.
Martino R, Caballero MD, Canals C et al. Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicenter study. Br J Haematol 2001; 115: 653–659.
Slevin ML, Plant H, Lynch D et al. Who should measure quality of life, the doctor or the patient? Br J Cancer 1998; 57: 109–112.
Aaronson NK, Ahmedzai S, Bergman B et al. The European organization for research and treatment of cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365–376.
Kopp M, Schweigkofler H, Holzner B et al. EORTC QLQ-C30 and FACT-BMT for the measurement of quality of life in bone marrow transplant recipients: a comparison. Eur J Hematol 2000; 65: 97–103.
Cella DF, Tulsky DS, Gray G et al. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11: 570–579.
McQuellon RP, Russell GB, Cella DF et al. Quality of life measurement in bone marrow transplantation: development of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) scale. Bone Marrow Transplant 1997; 19: 357–368.
Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825–828.
Caballero MD, Rubio V, Rifón J et al. BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors. Bone Marrow Transplant 1997; 20: 451–458.
Sureda A, Arranz R, Iriondo A et al. Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Espanol de Linfomas/Transplante Autologo de Medula Osea Spanish Cooperative Group. J Clin Oncol 2001; 19: 1395–1404.
Caballero MD, Perez-Simon JA, Iriondo A et al. High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol 2003; 14: 140–151.
Arnau J . Diseños longitudinales aplicados a las CC.SS. y del comportamiento. Limusa: México, 1995.
Kirk RE . Experimental Design: Procedures for the Behaviorial Sciences, (2nd edn) Brooks/Cole: Monterrey, 1982.
Maxwell SE, y Delaney HD . Designing Experiments and Analysis of Data – A Model Comparison Perspective. Wadsworth Publishing Company: Beltmont, 1990.
Armitage JO . Bone Marrow Transplantation. N Eng J Med 1994; 330: 827–838.
Klingemann HG, Storb R, Fefer A et al. Bone marrow transplantation in patients aged 45 years and older. Blood 1986; 65: 770–776.
Chiodi S, Spinelli S, Ravera G et al. Quality of life in 244 recipients of allogeneic bone marrow transplantation. Br J Haematol 2000; 110: 614–619.
Hjermstad JR, Kaasa S . Quality of life in adult cancer patients treated with bone marrow transplantation – a review of the literature. Eur J Cancer Care 1995; 31A: 163–173.
Pérez-Simón JA, Martino R, Alegre A et al. Chronic but not acute graft versus host disease improves outcome in multiple myeloma patients after nonmyeloablative allogeneic transplantation. Br J Hematol 2003; 121: 104–108.
Vickberg S, Duhamel KN, Smith MY et al. Global meaning and psychological adjustment among survivors of bone marrow transplant. Psycho-oncology 2001; 10: 29–39.
Andrykowski MA, Greiner CB, Altmaier EM et al. Quality of life following bone marrow transplantation: findings from a multicenter study. Br J Cancer 1995; 71: 1322–1329.
Andrykowski MA, Carpenter JS, Greiner CB et al. Energy level and sleep quality following bone marrow transplantation. Bone Marrow Transplant 1997; 20: 669–679.
Hann DM, Jacobsen PB, Martin SC et al. Quality of life following bone marrow transplantation for breast cancer: a comparative study. Bone Marrow Transplant 1997; 19: 257–264.
Whedon M, Stearns D, Millis LE . Quality of life of long-term adult survivors of autologous bone marrow transplantation. Oncol Nursing Forum 1995; 22: 1322–1329.
McQuellon RP, Craven B, Russell GB et al. Quality of life in breast cancer patients before and after autologous bone marrow transplantation. Bone Marrow Transplant 1996; 18: 579–584.
Syrjala KL, Chapko MK, Vitaliano PP et al. Recovering after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning. Bone Marrow Transplant 1993; 11: 319–327.
Acknowledgements
To Amelia de León and Inmaculada García-Palomero for their contribution to this study.
Author information
Authors and Affiliations
Corresponding author
Appendix A: English version questionnaire
Appendix A: English version questionnaire
FACT-BMT (version 3)
Below is a list of statements that other people with your illness have said are important. By circling one number per line, please indicate how true each statement has been for you during the past 7 days.
Physical well-being (not at all, a little bit, some-what, quite a bit, very much)
- 1 :
-
I have a lack of energy.
- 2 :
-
I have nausea.
- 3 :
-
Because of my physical condition, I have trouble meeting the needs of my family.
- 4 :
-
I have pain.
- 5 :
-
I am bothered by side-effects of treatment.
- 6 :
-
I feel sick.
- 7 :
-
I am forced to spend time in bed.
- 8 :
-
Looking at the above 7 questions, how much would you say your Physical Well-Being affects your quality of life?
Social/family well-being (not at all, a little bit, some-what, quite a bit, very much)
- 9 :
-
I feel distant from my friends.
- 10 :
-
I get emotional support from my family.
- 11 :
-
I get support from my friends and neighbors.
- 12 :
-
My family has accepted my illness.
- 13 :
-
Family communication about my illness is poor.
- 14 :
-
I feel close to my partner (or the person who is my main support).
- 15 :
-
Have you been sexually active during the past year? No/Yes If yes: I am satisfied with my sex life.
- 16 :
-
Looking at the above seven questions, how much would you say your life Social/Family Well-Being affects your quality of life?
Relationship with doctor (not at all, a little bit, some-what, quite a bit, very much)
- 17 :
-
I have confidence in my doctor(s).
- 18 :
-
My doctor is available to answer my questions.
- 19 :
-
Looking at the above two questions, how much would you say your Relationship with the Doctor affects your quality of life?
Emotional well-being (not at all, a little bit, some-what, quite a bit, very much)
- 20 :
-
I feel sad.
- 21 :
-
I am proud of how I'm coping with my illness.
- 22 :
-
I am losing hope in the fight against my illness.
- 23 :
-
I feel nervous.
- 24 :
-
I worry about dying.
- 25 :
-
I worry that my condition will get worse.
- 26 :
-
Looking at the above six questions, how much would you say your Emotional Well-Being affects your quality of life?
Functional well-being (not at all, a little bit, some-what, quite a bit, very much)
- 27 :
-
I am able to work (include work in home).
- 28 :
-
My work (include work in home) is fulfilling.
- 29 :
-
I am able to enjoy life.
- 30 :
-
I have accepted my illness.
- 31 :
-
I am sleeping well.
- 32 :
-
I am enjoying the things I usually do for fun.
- 33 :
-
I am content with the quality of my life right now.
- 34 :
-
Looking at the above seven questions, how much would you say your Functional Well-Being affects your quality of life?
Additional concerns (not at all, a little bit, some-what, quite a bit, very much)
- 35 :
-
I am concerned about keeping my job (include work in home).
- 36 :
-
I feel distant from other people.
- 37 :
-
I worry that the transplant will not work.
- 38 :
-
The effects of treatment are worse than I had imagined.
- 39 :
-
I have a good appetite.
- 40 :
-
I like the appearance of my body.
- 41 :
-
I am able to get around by myself.
- 42 :
-
I get tired easily.
- 43 :
-
I am interested in having sex.
- 44 :
-
I have concerns about my ability to have children.
- 45 :
-
I have confidence in my nurse(s).
- 46 :
-
I regret having the bone marrow transplant.
- 47 :
-
Looking at the above 12 questions, how much would you say these Additional Concerns affect your quality of life?
Additional items regarding GVHD symptoms:
- 48 :
-
Shortness of breath.
- 49 :
-
Need of rest.
- 50 :
-
Itching.
- 51 :
-
Any ocular disturbances.
- 52 :
-
Any disturbances in mouth.
- 53 :
-
Pain had interfered in my daily activity.
- 54 :
-
Fatigue.
- 55 :
-
Cough.
Rights and permissions
About this article
Cite this article
Díez-Campelo, M., Pérez-Simón, J., González-Porras, J. et al. Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study. Bone Marrow Transplant 34, 729–738 (2004). https://doi.org/10.1038/sj.bmt.1704646
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704646